Los Angeles Capital Management LLC Mersana Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 189,660 shares of MRSN stock, worth $330,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,660
Previous 175,420
8.12%
Holding current value
$330,008
Previous $352,000
1.7%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MRSN
# of Institutions
121Shares Held
116MCall Options Held
233KPut Options Held
457K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$33.7 Million1.59% of portfolio
-
Nextech Invest Ag12.1MShares$21 Million3.72% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$19.7 Million2.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$15.1 Million2.94% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$14.6 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $169M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...